Mendrisio
Switzerland
14
2025-07-24
The entities that hold a legal rights for patent applications filed by inventor Lovati Emanuela:
Emanuela Lovati from Mendrisio, CH has applied for patents for these inventions. The list has both pending applications and granted patents:
Piperidine Urea Derivatives for Use as Inotropic Agents
#2 | 2025-06-26Piperidine Urea Derivatives for Use as Inotropic Agents
#3 | 2024-08-22Piperidine Urea Derivatives for Use as Inotropic Agents
#4 | 2024-01-04Methods of Using 4-Amino-N-[4-(Methoxymethyl)Phenyl]-7-(1-Methylcyclopropyl)-6-(3-Morpholinoprop-1-YN-1-YL)-7H-Pyrrolo[2,3-D]Pyrimidine-5-Carboxamide for the Treatment of Tumors
#5 | 2022-12-22Process for the synthesis of substituted chloromethyl dialkylphosphates
#6 | 2020-12-24Fosnetupitant chloride hydrochloride having improved stability
#7 | 2019-06-13Substituted piperaziniums for the treatment of emesis
#8 | 2018-07-12Solution comprising the chloride hydrochloride salt of 4-(5-(2-(3,5-bis(trifluoromethyl)phenyl)-N,2-dimethylpropanamido)-4-(o-tolyl)pyridin-2-yl)-1-methyl-1-((phosphonooxy)methyl)piperazin-1-IUM-(fosnetupitant) and palonosetron hydrochloride in combination with dexamethasone as a neurokinin receptor modulator
#9 | 2018-06-28Therapeutic Uses of Elsiglutide
#10 | 2017-03-30Therapeutic Uses of Elsiglutide
#11 | 2017-02-23Substituted piperaziniums for the treatment of emesis
#12 | 2015-01-084-(5-(2-(3,5-bis(trifluoromethyl)phenyl)-N,2-dimethylpropanamido)-4-(o-tolyl)pyridin-2-yl)-1-methyl-1-((phosphonooxy)methyl)piperazin-1-ium as a neurokinin receptor modulator
#13 | 2013-09-05Methods of treating emesis
#14 | 2013-04-23Substituted 4-phenyl pyridines having anti-emetic effect
425466 ⎘